| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 75.37B | 72.77B | 69.89B | 62.51B | 50.23B |
| Gross Profit | 11.00B | 42.34B | 9.65B | 8.05B | 6.81B |
| EBITDA | 12.98B | 12.78B | 11.99B | 10.54B | 7.79B |
| Net Income | 4.90B | 4.86B | 4.70B | 4.26B | 2.60B |
Balance Sheet | |||||
| Total Assets | 133.06B | 129.49B | 118.56B | 111.99B | 100.82B |
| Cash, Cash Equivalents and Short-Term Investments | 18.50B | 16.17B | 16.17B | 13.33B | 11.27B |
| Total Debt | 37.69B | 36.26B | 31.42B | 31.02B | 33.77B |
| Total Liabilities | 98.74B | 95.46B | 86.52B | 82.58B | 76.05B |
| Stockholders Equity | 30.75B | 29.95B | 28.11B | 25.94B | 22.88B |
Cash Flow | |||||
| Free Cash Flow | 8.01B | 7.66B | 7.21B | 5.89B | 5.74B |
| Operating Cash Flow | 11.89B | 11.71B | 10.54B | 9.39B | 7.81B |
| Investing Cash Flow | -5.26B | -9.05B | -3.98B | -5.30B | -5.80B |
| Financing Cash Flow | -4.27B | -3.03B | -3.43B | -2.78B | -3.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | €70.38B | 13.71 | 16.66% | 3.96% | 3.21% | 4.24% | |
69 Neutral | €12.53B | 11.12 | 14.39% | 3.87% | 7.71% | -2.82% | |
64 Neutral | €18.76B | 14.13 | 8.45% | 4.51% | 0.88% | -2.06% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | €7.24B | 190.12 | 8.70% | 2.14% | 10.87% | -10.35% | |
55 Neutral | €578.01M | 83.86 | 2.60% | 2.41% | 6.72% | -90.75% | |
48 Neutral | €8.19B | -0.89 | -46.54% | 6.19% | 8.44% | -937.75% |